Diagnostics in pulmonary hypertension.
暂无分享,去创建一个
[1] J. Marcus,et al. NT-proBNP reflects right ventricular structure and function in pulmonary hypertension , 2006, European Respiratory Journal.
[2] R. Khattar,et al. Pulmonary arterial hypertension: classification, diagnosis and contemporary management , 2006, Postgraduate Medical Journal.
[3] J. Behr,et al. Brain natriuretic peptide is a prognostic parameter in chronic lung disease. , 2006, American journal of respiratory and critical care medicine.
[4] Horst Olschewski,et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. , 2004, European heart journal.
[5] M. Humbert,et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. , 2004, Journal of the American College of Cardiology.
[6] M. Vogeser,et al. Clinical significance of brain natriuretic peptide in primary pulmonary hypertension. , 2004, Journal of the American College of Cardiology.
[7] A. Arroliga,et al. Diagnosis and evaluation of pulmonary hypertension. , 2003, Cleveland Clinic journal of medicine.
[8] J. Greenfield,et al. Electrocardiography to define clinical status in primary pulmonary hypertension and pulmonary arterial hypertension secondary to collagen vascular disease. , 2002, Chest.
[9] R. Hetzer,et al. Assessment of Survival in Patients With Primary Pulmonary Hypertension: Importance of Cardiopulmonary Exercise Testing , 2002, Circulation.
[10] W. Seeger,et al. Clinical classification of pulmonary hypertension. , 2001, Clinics in chest medicine.
[11] M. Rubenfire,et al. Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension. , 2001, The European respiratory journal.
[12] M. Fujita,et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. , 2000, American journal of respiratory and critical care medicine.
[13] I. Gurubhagavatula,et al. Pulmonary hypertension in systemic autoimmune disease. , 1997, Rheumatic diseases clinics of North America.
[14] A J Tajik,et al. Doppler echocardiographic index for assessment of global right ventricular function. , 1996, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[15] W. MacNee,et al. Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Part One. , 1994, American journal of respiratory and critical care medicine.
[16] S. Globits,et al. Detection and quantification of pulmonary artery hypertension with MR imaging: results in 23 patients. , 1993, AJR. American journal of roentgenology.
[17] H. Palevsky,et al. Chronic cor pulmonale : etiology and management , 1990 .
[18] L. Rubin,et al. Primary pulmonary hypertension. , 1997, The New England journal of medicine.
[19] E H Bergofsky,et al. Primary pulmonary hypertension. A national prospective study. , 1987, Annals of internal medicine.
[20] J. Widimský. Noninvasive Diagnosis of Pulmonary Hypertension in Chronic Lung Diseases , 1985 .
[21] P. Walden. Primary pulmonary hypertension , 1981 .
[22] A. Fishman. Chronic Cor Pulmonale , 1971 .
[23] E. Weitzenblum,et al. CHRONIC COR PULMONALE , 2003, Heart.
[24] L. Tavazzi,et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. , 2001, Journal of the American College of Cardiology.
[25] F. R. H. E. Pstein,et al. Mechanisms of Disease Mechanisms of Disease a Therosclerosis — a N I Nflammatory D Isease a Factors That Induce and Promote Inflammation or Atherogenesis , 2022 .